When a premature baby is born with respiratory distress syndrome (RDS), their lungs are stiff and need help to stay open so they can breathe. The standard first-line breathing support is called nasal CPAP, which delivers a steady stream of air. This study tested whether a newer method, called non-invasive high-frequency oscillation ventilation (NHFOV), is just as safe and effective when used as that first support.
The trial involved 142 premature babies, all at least 30 weeks along at birth, in a lower middle-income country. Half received the standard CPAP, and half received the newer NHFOV, both delivered through a nasal mask at the same pressure levels. The most important question was whether the newer method would fail, requiring a switch to a different support. The failure rate was identical for both groups: about 4 out of every 100 babies in each group needed to switch.
Crucially, the newer NHFOV method was proven to be just as safe as CPAP for preventing the need for a breathing tube and mechanical ventilation. Babies on the newer NHFOV also spent significantly less time on their primary breathing support—about 7 hours less on average—and had more days free from needing that support. The study concludes that NHFOV is a valid alternative to CPAP as the first breathing support for these babies, with the potential benefit of getting them off support sooner.